The tool uses a smartphone camera, a small 3D-printed box and a simple chemical test to show whether a dead mosquito belongs to the Aedes aegypti species. Vivian Abagiu
A new diagnostic tool has been developed by researchers at The University of Texas at Austin that can easily, quickly and cheaply identify whether a mosquito belongs to the species that carries dangerous diseases such as Zika virus, dengue, chikungunya or yellow fever. It can also determine whether the bug has come into contact with a mosquito-control strategy known as Wolbachia.
“Many of these diseases are spreading in areas where they weren’t common before,” said Sanchita Bhadra, a research associate in the Department of Molecular Biosciences and first author on the paper. “Having surveillance is important in conjunction with any kind of outbreak, and this method allows a rapid test in the field.”
The tool uses a smartphone camera, a small 3D-printed box and a simple chemical test to show whether a dead mosquito belongs to the Aedes aegypti species. Aedes aegypti carries Zika and other devastating viruses that afflict an estimated 100 million people worldwide each year. The species also is closely linked to the tripling of cases of mosquito-borne diseases in the United States since 2004.
The research appears in the journal PLOS Neglected Tropical Diseases.
The tool developed by scientists and students at UT Austin also detects the presence of a biopesticide called Wolbachia, a type of bacteria that keeps mosquitoes from spreading diseases. In countries around the world and in 20 U.S. states where the Aedes aegypti mosquito is found, scientists working in public health agencies have started to infect mosquitoes with Wolbachia by introducing the bacteria into a local mosquito population to help curb transmission of viruses.
Because mosquitoes show no outward signs of having the bacteria – and because existing diagnostic tests are hard to read, expensive and logistically cumbersome – the new tool represents a significant step forward for those hoping to monitor the effectiveness of Wolbachia.
“This test can happen without involving a lot of staff and equipment to make sure Wolbachia is effective and spreading as anticipated,” Bhadra said.
Public health groups trap and kill mosquitoes routinely in conjunction with monitoring efforts, but existing technology requires a complex process to extract nucleic acid from inside mosquitoes, often after they have been dead for days and have started to decay, leading to greater expense and the possibility of more errors in lab tests than the new technology.
The new diagnostic tool uses a smartphone’s camera and a simple test that can be done anywhere. It tests mosquitoes’ nucleic acid without requiring a complicated process to remove it. Officially known as a loop-mediated isothermal amplification and oligonucleotide strand displacement, or LAMP OSD, the probe delivers a simple yes-or-no readout on a cellphone, with accuracy of greater than 97 percent.
In addition to the tests to detect mosquito species and Wolbachia, the team also is exploring use of the technology to easily identify whether trapped mosquitoes are carrying Zika, dengue and other pathogens.
Learn more: Simple Test Detects Disease-Carrying Mosquitoes, Presence of Biopesticide
The Latest on: Disease diagnostic tool
via Google News
The Latest on: Disease diagnostic tool
- Why some hospitals have stopped using race-based calculations for kidney diseaseon May 19, 2022 at 2:05 pm
Studies show Black patients are more likely to have kidney failure than white patients. They also make it onto transplant lists later, and once they’re on the list, they wait longer to get a kidney.
- Minimally invasive diagnostic biomarker strategy successful in detecting early esophageal canceron May 19, 2022 at 6:05 am
In a small but rigorous pilot study, Johns Hopkins Medicine researchers have shown that a novel, minimally invasive biomarker-based strategy they developed was 90% successful in detecting esophageal ...
- C2N Diagnostics Introduces P-tau Multi-Analyte Assay for Research Use Only to Advance Alzheimer’s Disease and Brain Health Fieldon May 18, 2022 at 7:06 am
C 2 N Diagnostics, a leader in advanced brain health diagnostics that offers the PrecivityAD™ blood test as an aid to Alzheimer’s disease diagnosis, today announced its latest innovative offering for ...
- Alzheimer’s disease Diagnostic Market Size, Share, Trends, Business Strategies, Revenue, Leading Players, Opportunities and Forecast 2027on May 18, 2022 at 3:29 am
The Alzheimer’s disease Diagnostic Market Share is projected to increase ... technological advancements in the manufacture of detection and diagnostic tools, and the rapid discovery of drugs to treat ...
- Viral Disease Diagnosis Market is Expected to Reach US$ 39.8 Bn by 2026on May 16, 2022 at 11:29 pm
Snapshot. The latest corporate intelligence studies report that the global viral disease diagnosis market is anticipated to grow commendably ...
- AI tool could dramatically decrease diagnostic times for psoriatic arthritis patientson May 16, 2022 at 7:56 am
Researchers in Israel have shown that a new machine-learning tool can speed up the diagnosis of psoriatic ... suffer from psoriasis (a chronic skin disease). The most common symptoms are joint ...
- New AI tool can speed up the diagnosis of psoriatic arthritis by up to 4 yearson May 15, 2022 at 11:35 am
Researchers in Israel have shown that a new machine-learning tool can speed up the diagnosis of psoriatic arthritis (PsA) by up to 4 years, potentially preventing irreversible joint damage and ...
- BD launches automated infectious disease diagnostic platformon May 12, 2022 at 11:36 am
BD has launched a fully automated, high-throughput infectious disease molecular diagnostics platform in the U.S.
- BD launches automated infectious disease diagnostic platform in the U.S.on May 12, 2022 at 7:46 am
BD (NYSE:BDX) announced today that it began the U.S. launch of its new, fully automated, high-throughput diagnostic platform.
- FDA grants marketing authorization to Fujirebio's diagnostic test for Alzheimer's diseaseon May 6, 2022 at 11:00 am
A Malvern biotech firm received marketing clearance from the FDA for its diagnostic test designed to help better evaluate patients for Alzheimer's disease.
via Bing News